BioNet News 23 May 2025 BioNet x Isaanbags: A CSR Story of Craft and Care BioNet is happy to support Isaanbags, a local brand from Kalasin province, Thailand. This project helps the community by creating… Pantitra
BioNet News 11 Apr 2025 New Research Boosts Future Whooping Cough Vaccines Whooping cough, or pertussis, was once a leading cause of death for children in the U.S. and worldwide before the… Pantitra
BioNet News 28 Feb 2025 Infant Responses to Primary Immunization Following Vaccination in Pregnancy With Varying Doses of Recombinant Acellular Pertussis Vaccine Alone or Combined With Tetanus-Diphtheria Pertussis is a highly contagious infectious disease of the respiratory tract caused by Bordetella pertussis. Disease is most severe in young… Pantitra
BioNet News 17 Jan 2025 BioNet Wins BARDA Patch Forward Prize for Microneedle mRNA Vaccine Innovation Lyon, France & Bangkok, Thailand – January 17, 2025 – BioNet, a global leader in vaccine innovation, proudly announces its… Supachai
BioNet News 15 Jan 2025 LTS and BioNet Win U.S. BARDA Patch Forward Prize Competition Andernach – LTS, a leading pharmaceutical technology company, and BioNet, a biotech manufacturer specializing in genetically engineered vaccines, announced today… Supachai
BioNet News 03 Jan 2025 BioNet’s Support for Local Communities BioNet recently teamed up with the Social Development and Human Security Office of Ayutthaya, and local volunteers to visit vulnerable… Supachai
BioNet News 31 Dec 2024 A reduced-dose recombinant pertussis vaccine booster in Thai adolescents: a phase 2/3, observer-blinded, randomised controlled, non-inferiority trial Pertussis, also known as whooping cough, is an acute respiratory disease caused by Bordetella pertussis, a bacterium that is transmitted between… Pantitra
BioNet News 30 Dec 2024 Pertussis Immunity 5 Years After Booster Vaccination With Recombinant Pertussis Vaccines Pertussis remains one of the least controlled vaccine-preventable diseases. Pertussis booster vaccines are associated with fast-waning immunity and offer only… Pantitra
BioNet News 31 Jul 2024 BioNet Recombinant Pertussis Vaccine Submitted to EMA BioNet’s Recombinant Pertussis Vaccine Submitted to European Medicines Agency (EMA) "Monovalent recombinant acellular pertussis vaccine proven to significantly boost immunity… Supachai
BioNet News 30 Jul 2024 Transplacental transfer of maternal antibodies following immunization with recombinant pertussis vaccines during pregnancy: Real-world evidence Pertussis, caused by Bordetella pertussis, is a highly contagious respiratory disease that poses a significant risk to young infants, resulting in both severe morbidity… Pantitra
